Upregulation of the Long Noncoding RNA CASC10 Promotes Cisplatin Resistance in High-Grade Serous Ovarian Cancer

Despite initial responses to first-line treatment with platinum and taxane-based combination chemotherapy, most high-grade serous ovarian carcinoma (HGSOC) patients will relapse and eventually develop a cisplatin-resistant fatal disease. Due to the lethality of this disease, there is an urgent need...

Descripción completa

Detalles Bibliográficos
Autores principales: Noriega-Rivera, Ricardo, Rivera-Serrano, Mariela, Rabelo-Fernandez, Robert J., Pérez-Santiago, Josué, Valiyeva, Fatima, Vivas-Mejía, Pablo E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318856/
https://www.ncbi.nlm.nih.gov/pubmed/35887085
http://dx.doi.org/10.3390/ijms23147737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318856/
https://www.ncbi.nlm.nih.gov/pubmed/35887085
http://dx.doi.org/10.3390/ijms23147737

Ejemplares similares